-
公开(公告)号:US20120319052A1
公开(公告)日:2012-12-20
申请号:US13581543
申请日:2011-01-21
IPC分类号: H01B1/12 , C07D513/00 , C08G73/06 , C07D401/10
CPC分类号: H01L51/0072 , C07D401/04 , C07D401/10 , C07D471/06 , C07D471/16 , C07D498/06 , C07D513/06 , C07D519/00 , C09B19/00 , C09B57/00 , C09K11/025 , H01L51/0061 , H01L51/0071 , H01L51/5012 , H01L51/5016 , H01L51/5048 , H01L51/5056 , H01L51/5088 , H01L2251/5384 , Y02E10/549
摘要: The present invention relates to compounds of the formula (1) or (2) and to the use thereof in electronic devices, and to electronic devices which comprise these compounds. The invention furthermore relates to the preparation of the compounds of the formula (1) or (2) and to formulations comprising one or more compounds of the formula (1) or (2).
摘要翻译: 本发明涉及式(1)或(2)的化合物及其在电子器件中的应用以及包含这些化合物的电子器件。 本发明还涉及式(1)或(2)化合物的制备和包含一种或多种式(1)或(2)的化合物的制剂。
-
公开(公告)号:US08283361B2
公开(公告)日:2012-10-09
申请号:US12477781
申请日:2009-06-03
IPC分类号: A61K31/04 , C07D215/38
CPC分类号: C07D417/14 , C07D498/06
摘要: Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
摘要翻译: 描述式(I)化合物及其药学上可接受的盐。 还描述了其制备方法,含有它们的药物组合物,其作为药物的用途及其在治疗细菌感染中的用途。
-
公开(公告)号:US20120251581A1
公开(公告)日:2012-10-04
申请号:US13433944
申请日:2012-03-29
CPC分类号: C07K5/06078 , A61K38/06 , C07D498/04 , C07D498/06 , C07K5/06191 , C07K5/0808
摘要: There is provided inter alia a compound of formula (I): for use in treatment of viral infection or as an immunosuppressant.
摘要翻译: 特别提供式(I)化合物:用于治疗病毒感染或作为免疫抑制剂。
-
公开(公告)号:US08173840B2
公开(公告)日:2012-05-08
申请号:US11343557
申请日:2006-01-30
申请人: V. Ravi Chandran
发明人: V. Ravi Chandran
IPC分类号: C07K229/00
CPC分类号: A61K38/12 , A61K47/542 , C07C229/08 , C07C229/22 , C07C229/26 , C07C229/36 , C07C233/47 , C07C2602/22 , C07D207/33 , C07D209/10 , C07D209/14 , C07D211/34 , C07D211/90 , C07D215/38 , C07D217/26 , C07D223/16 , C07D239/10 , C07D261/20 , C07D265/18 , C07D275/04 , C07D295/185 , C07D311/24 , C07D311/32 , C07D333/58 , C07D401/06 , C07D401/12 , C07D403/10 , C07D405/14 , C07D409/06 , C07D413/06 , C07D473/18 , C07D473/34 , C07D493/04 , C07D493/10 , C07D495/04 , C07D498/06 , C07D498/14 , C07D499/14 , C07D501/22 , C07D501/34 , C07D501/46 , C07D501/56 , C07F9/572 , C07F9/65616 , Y02A50/411
摘要: The present invention is directed to novel therapeutic compounds comprised of an amino acid bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. These high therapeutic index derivatives have the same utility as the drug from which they are made, and they have enhanced pharmacological and pharmaceutical properties. In fact, the novel drug derivatives of the present invention enhance at least one therapeutic quality, as defined herein. The present invention is also directed to pharmaceutical compositions containing same.
摘要翻译: 本发明涉及由与其上具有羟基,氨基,羧基或酰化衍生物的药物或药物结合的氨基酸组成的新型治疗化合物。 这些高治疗指数衍生物与其制备的药物具有相同的效用,并且它们具有增强的药理学和药物性质。 事实上,本发明的新型药物衍生物增强至少一种如本文所定义的治疗质量。 本发明还涉及含有其的药物组合物。
-
公开(公告)号:US20110301141A1
公开(公告)日:2011-12-08
申请号:US13150929
申请日:2011-06-01
申请人: Charles Baker-Glenn , Daniel Jon Burdick , Mark Chambers , Bryan K. Chan , Huifen Chen , Anthony Estrada , Janet Gunzner-Toste , Daniel Shore , Zachary Sweeney , Shumei Wang , Guiling Zhao
发明人: Charles Baker-Glenn , Daniel Jon Burdick , Mark Chambers , Bryan K. Chan , Huifen Chen , Anthony Estrada , Janet Gunzner-Toste , Daniel Shore , Zachary Sweeney , Shumei Wang , Guiling Zhao
IPC分类号: A61K31/5377 , C07D401/12 , C07D401/14 , A61P25/16 , A61K31/506 , A61K31/5386 , A61K31/553 , C07D413/12 , C07D403/12
CPC分类号: C07D413/14 , C07D403/14 , C07D413/12 , C07D473/16 , C07D498/06 , C07D498/08
摘要: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
摘要翻译: 式I化合物或其药学上可接受的盐,其中m,n。 X,R 1,R 2,R 3,R 5,R 6和R 7如本文所定义。 还公开了制备化合物和使用该化合物治疗与LRRK2受体(例如帕金森病)相关的疾病的方法。
-
公开(公告)号:US08063047B2
公开(公告)日:2011-11-22
申请号:US12119208
申请日:2008-05-12
申请人: Martin Watterson , Linda Van El Dik , Jacques Haiech , Marcel Hibert , Jean-Jacques Bourguignon , Anastasia Veleniza , Wenhui Hu , Magdaena Zasadzki
发明人: Martin Watterson , Linda Van El Dik , Jacques Haiech , Marcel Hibert , Jean-Jacques Bourguignon , Anastasia Veleniza , Wenhui Hu , Magdaena Zasadzki
IPC分类号: C07D237/26 , A61K31/502 , A61P29/00 , A61P25/04 , A61P25/28 , A61P25/16 , A61P25/24 , A61P25/18
CPC分类号: C07D403/12 , C07D237/36 , C07D401/12 , C07D401/14 , C07D498/06
摘要: The invention relates to novel chemical compounds of Formula I compositions and methods of using the same. In particular, the invention provides pyridazine compounds and/or related heterocyclic derivatives, compositions comprising the same, and methods of using pyridazine compounds and/or related heterocyclic derivatives and compositions comprising the same, for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications.
摘要翻译: 本发明涉及式I组合物的新型化合物及其使用方法。 特别地,本发明提供哒嗪化合物和/或相关的杂环衍生物,包含其的组合物,以及使用哒嗪化合物和/或相关杂环衍生物的方法及其组合物,用于调节细胞途径(例如,信号转导途径) ,用于治疗或预防炎性疾病(如阿尔茨海默病),用于研究,药物筛选和治疗应用。
-
公开(公告)号:US20110065687A1
公开(公告)日:2011-03-17
申请号:US12596240
申请日:2008-04-17
IPC分类号: A61K31/5377 , C07D513/14 , A61K31/497 , A61K31/496 , A61K31/551 , C07D498/04 , C07D471/04 , C07D513/04 , C07D498/14 , A61K31/5383 , A61K31/4985 , A61K31/542 , A61P35/00 , A61P31/12 , A61P31/04 , A61P31/10
CPC分类号: C07D498/06 , C07D471/06 , C07D471/14 , C07D498/16 , C07D513/06 , C07D513/14
摘要: This application relates to certain novel polycyclic compounds that interact with quadruplex-forming regions of polynucleotides and thereby inhibit translation of genetic information into polypeptides. These compounds can thus provide anticancer and antibacterial and antiviral effects. The invention includes novel compounds and pharmaceutical compositions, and methods of using them to treat cancer and other conditions.
摘要翻译: 本申请涉及与多核苷酸的四连体形成区相互作用并从而抑制遗传信息转化为多肽的某些新型多环化合物。 因此,这些化合物可提供抗癌和抗细菌和抗病毒作用。 本发明包括新型化合物和药物组合物,以及使用它们治疗癌症和其它病症的方法。
-
公开(公告)号:US07875722B2
公开(公告)日:2011-01-25
申请号:US12569938
申请日:2009-09-30
申请人: Koji Sato , Kenji Sakuratani
发明人: Koji Sato , Kenji Sakuratani
IPC分类号: C07D215/56 , C07D295/155 , C07D291/04 , C07D265/28
CPC分类号: C07D215/56 , C07D401/04 , C07D498/06
摘要: The present invention relates to a method for producing a quinolone compound having high antibacterial activity and high safety, at high yield and in a simple manner.A quinolonecarboxylic acid derivative (1) of interest is produced through a one-pot manner by reacting a compound (2) with a salt of a cyclic amine (3) and with a boron derivative in a solvent in the presence of a base.
摘要翻译: 本发明涉及以高产率和简单的方式生产具有高抗菌活性和高安全性的喹诺酮化合物的方法。 通过使化合物(2)与环胺(3)的盐与硼衍生物在溶剂中在碱的存在下反应,通过一锅方式制备目标的喹诺酮羧酸衍生物(1)。
-
公开(公告)号:US20110003800A1
公开(公告)日:2011-01-06
申请号:US12797712
申请日:2010-06-10
申请人: Mark J. Macielag , Mingde Xia , Xiaoqing Xu
发明人: Mark J. Macielag , Mingde Xia , Xiaoqing Xu
IPC分类号: A61K31/5383 , C07D235/30 , C07D498/06 , A61K31/4184 , A61P9/12 , A61P9/00 , A61P25/04 , A61P29/00
CPC分类号: A61K31/5383 , A61K31/4184 , C07D233/52 , C07D235/30 , C07D498/06
摘要: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein R0, R1, R2, R3, R4 and a are defined herein.
-
公开(公告)号:US20100069446A1
公开(公告)日:2010-03-18
申请号:US12557030
申请日:2009-09-10
申请人: V. Ravi Chandran
发明人: V. Ravi Chandran
IPC分类号: A61K31/44 , C07C229/02 , A61K31/22 , C07D307/93 , A61K31/343 , C07D213/80 , C07D233/54 , A61K31/4164 , A61P43/00
CPC分类号: A61K38/12 , A61K38/10 , A61K45/06 , A61K47/542 , C07C229/08 , C07C229/22 , C07C229/26 , C07C229/36 , C07C233/47 , C07C2602/22 , C07D207/33 , C07D209/10 , C07D209/14 , C07D211/34 , C07D211/90 , C07D215/38 , C07D217/26 , C07D223/16 , C07D239/10 , C07D261/20 , C07D265/18 , C07D275/04 , C07D295/185 , C07D311/24 , C07D311/32 , C07D333/58 , C07D401/06 , C07D401/12 , C07D403/10 , C07D405/14 , C07D409/06 , C07D413/06 , C07D473/18 , C07D473/34 , C07D493/04 , C07D493/10 , C07D495/04 , C07D498/06 , C07D498/14 , C07D499/14 , C07D501/22 , C07D501/34 , C07D501/46 , C07D501/56 , C07F9/572 , C07F9/65616
摘要: The present invention is directed to a derivative comprised of an L-Threonine bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. The derivative has the same utility as the drug from which it is made, but it has enhanced therapeutic properties. In fact, the derivatives of the present invention enhance at least one or more therapeutic qualities, as defined herein. The present invention is also directed to pharmaceutical compositions containing same.
-
-
-
-
-
-
-
-
-